Ireland· IE-PA-EU/1/14/962/001-003
Moventig 12.5 mg film-coated tablets
A naloxegol product containing naloxegol oxalate, registered in Ireland by Grünenthal GmbH. The same ATC class is registered in 15 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Naloxegol is registered in 15 of 19 countries.
Countries holding a registration under ATC A06AH03 (naloxegol), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 10 of them publish a price we can compare per daily dose
Naloxegol · ATC A06AH03
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of naloxegol costs, country by country.
Normalised to the WHO defined daily dose (25 mg), the median price runs from $3.62 in Italy to $5.84 in Spain — a ×1.6 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Naloxegol · price per daily dose (25 mg)
USD · FX 28 Sept 2026
- ES Spain$5.84
- CH Switzerland$5.75
- FR France$3.80
- IT Italy$3.62
The record
At a glance
HPRA (Ireland)- Active substance
- Naloxegol oxalate
- Manufacturer
- Grünenthal GmbH
- Country
- Ireland (IE)
- ATC code
- A06AH03
- ATC class
- Naloxegol
- Defined daily dose
- 25 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/14/962/001-003
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
204 interactions on record for naloxegol.
Graded by severity as the source publishes them — 66 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Naloxegol · interactions on record
204 records
- 66 severe
- 57 moderate
- 81 minor
Most severe, free to view
- AprepitantA04AD12severe
- DanazolG03XA01severe
- LonafarnibA16AX20severe
- BerotralstatB06AC06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Naloxegol in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9b2a35b6-a964-409c-9d29-c0b10bff85d0 GET /v1/drugs/9b2a35b6-a964-409c-9d29-c0b10bff85d0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"A06AH03"
],
"strength": null,
"pa_number": "EU/1/14/962/001-003",
"substances": [
"Naloxegol oxalate"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "08/12/2014",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about naloxegol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.